[Relation between a circulating inhibitor of sodium transport and arterial hypertension].
D000818:Animals; D001693:Biological Transport, Active; D001798:Blood Proteins; D002118:Calcium / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000097:blood*; D007031:Hypothalamus / Q000378:metabolism; D011506:Proteins / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D014655:Vascular Resistance; D000097795:ATPase Inhibitory Protein
D001798:Blood Proteins; D002118:Calcium; D011506:Proteins; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D000097795:ATPase Inhibitory Protein
Relación entre un inhibidor circulante del transporte de sodio y la hipertensión arterial.